Oncology

At the 2025 ESGO Annual Meeting, researchers unveiled two new diagnostic indices “Vienna Index” and “Top Vienna Index” which combine age with existing ovarian cancer biomarkers, significantly improving detection accuracy.

Study reveals a protein model to predict cardiomyopathy in childhood cancer survivors, enhancing early detection and intervention.

Aspirin was well-tolerated but did not significantly improve disease-free survival in high-risk colorectal cancer patients.

Personalised cancer vaccines show promise in preventing recurrence of high-risk kidney cancer, targeting key driver mutations.

U-Net neural network achieves 98.56% accuracy in brain tumour segmentation, promising advancements in neurological diagnostics and treatment planning.

Study reveals cancer survivors have lower dementia risk, suggesting potential shared biological mechanisms between cancer and neurodegeneration.

Study finds tumour-infiltrating lymphocytes linked to survival in early ERBB2-positive breast cancer, suggesting treatment de-escalation may be possible

New research reveals how aging rewires mammary gland cells, increasing breast cancer risk through epigenetic and immune changes.